Startups
Type 2 Diabetes Treatment to Lower A1C
Edit

Type 2 Diabetes Treatment to Lower A1C

Trusted
https://www.mounjaro.com/
Last activity: 19.03.2026
Active
Categories: Learn
Mounjaro (tirzepatide) is a once-weekly non-insulin injection for adults to help lower A1C along with diet and exercise. Learn how Mounjaro works and how to get started.
Website visits
614.1K /mo.
Mentions
34

Mentions in press and media 34

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Feb 23, 2026Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one penEli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month’s worth of doses in a single pen. The pen could serve as a more convenient option for some patients, as it reduces the number of devices ...
Jan 23, 2026Gucci to Zara: Brands ramp up fight against domain ‘squatting’Global legal disputes over ‘squatted’ web addresses rose to 6,282 cases last year as big companies, especially fashion brands, are fighting back against counterfeit goods. According to data by Mathys & Squire shared with City AM, disput...
Dec 17, 2025This biotech name is evolving into a major obesity play. How to trade it with options
May 22, 2025The Weight of Change: India’s Looming Obesity CrisisIndia stands at a crossroads. The nation is grappling with a growing obesity epidemic that threatens to become a public health crisis. As lifestyles shift and fast food becomes the norm, the consequences are dire. The statistics are stagger...
May 21, 2025Obesity could become public health crisis in India if left unchecked, say health expertsListen 4 min New: You can now listen to articles. This audio is generated by an AI tool. MUMBAI: Vishwanath Gaitonde has struggled with his weight for years – and the problem only grew when he reached his 50s. The advertising business head,...
May 13, 2025The Price of Health: Trump’s Bold Move Against Drug CostsIn a bold stroke, President Donald Trump has taken aim at the soaring prices of prescription drugs in the United States. His recent executive order targets weight-loss medications, specifically the popular drugs Wegovy and Zepbound. The goa...
May 13, 2025Trump calls out weight-loss drugs as target of price-cut pushTrump calls out weight-loss drugs as target of price-cut push By Deena BeasleyMay 12, 20259:17 PM UTCUpdated ago Text Small Text Medium Text Large Text Share X Facebook Linkedin Email Link A combination image shows an injection pen of Zepbo...
May 3, 2025The Cost of Health: GLP-1s and the Future of Employer HealthcareIn the world of healthcare, costs often rise like a tide, relentless and overwhelming. But a new wave is forming, one that promises to reshape the landscape of employer-sponsored health plans. This wave is driven by GLP-1 medications, a cla...
Apr 30, 2025GLP-1s can help employers lower medical costs in 2 years, new study findsAon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for 139,000 U.S.-based workers with employer heal...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Type 2 Diabetes Treatment to Lower A1C

What has the press written about Type 2 Diabetes Treatment to Lower A1C?

Parsers VC has collected 34 articles mentioning Type 2 Diabetes Treatment to Lower A1C, among them “Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen” (Feb 23, 2026) and “Gucci to Zara: Brands ramp up fight against domain ‘squatting’” (Jan 23, 2026).

Is Type 2 Diabetes Treatment to Lower A1C still active?

Yes, Type 2 Diabetes Treatment to Lower A1C is active; its latest activity on Parsers VC dates from Mar 19, 2026.